3+ day, 12+ hour ago   (352+ words) Lunit said Friday that 10x Genomics will incorporate its AI-powered pathology platform, Lunit SCOPE IO, into an oncology biomarker discovery workflow combining pathology images with spatial molecular data. Lunit SCOPE IO will be used to analyze hematoxylin and eosin (H&E)-stained…...

3+ day, 12+ hour ago   (726+ words) China’s rapid rise in cancer research, fueled by heavy state investment, is challenging Korea to rethink a system that has long depended heavily on individual researchers, Korean cancer experts said Thursday. The warning comes as AI and big data increasingly…...

4+ day, 8+ hour ago   (470+ words) If the remaining administrative procedures proceed as scheduled, reimbursement would come about four and a half years after the drug received Ministry of Food and Drug Safety (MFDS) approval in March 2022. The expected listing would mark the culmination of a…...

4+ day, 9+ hour ago   (451+ words) ROKIT Healthcare has signed a distribution agreement to introduce its AI-based skin regeneration platform in China’s Hainan Boao Lecheng International Medical Tourism Pilot Zone. Following local administrative approvals and hospital adoption procedures, ROKIT Healthcare plans to conduct its first skin…...

4+ day, 10+ hour ago   (459+ words) Korea’s rare-disease drug market grew nearly fivefold over the past decade to about 1.2 trillion won ($896 million) in 2025, outpacing the broader pharmaceutical market, according to an IQVIA Korea analysis. IQVIA Korea said Thursday the findings were based on sales data from…...

5+ day, 8+ hour ago   (292+ words) Macrogen, a Korean genomics company, said on Wednesday it would become the first company in Asia to offer Atera, a tissue-analysis platform made by the U.S. firm 10x Genomics, adding to the services it sells to researchers working on precision medicine and…...

5+ day, 8+ hour ago   (386+ words) The head of the United Arab Emirates' pharmaceutical regulator visited Biosolution and Helixmith's research center in Seoul to discuss regulatory cooperation and potential market entry for Korean cell and gene therapies in the Middle East. Biosolution said Wednesday that Fatima…...

6+ day, 6+ hour ago   (1179+ words) The government will gradually cut health insurance copayments for patients with rare and severe intractable diseases from 10 percent to 7 percent this year and 5 percent in 2028. The government will also expand support for insulin pumps and continuous glucose monitors to patients…...

6+ day, 7+ hour ago   (348+ words) The government has decided to freeze the national health insurance premium rate at 7.19 percent in 2027, citing stable finances and expected support from the government and premium revenue. The Ministry of Health and Welfare said that the Health Insurance Policy Deliberation…...

6+ day, 12+ hour ago   (792+ words) SK biopharmaceuticals is strengthening its R&D capabilities by bringing in global experts across drug discovery and clinical development, while focusing on physician-led development that incorporates patient needs and clinical practice early in the process. The company said Tuesday that…...